High-Efficacy DMTs: Transforming MS Care
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Ahmed Zayed Obeidat, MD, PhD
Balancing Act: Immune Reconstitution vs Immune Suppression
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
PROs in MS: A New Era of Patient-Centric Care
Imaging Biomarkers: MS Progression in Focus
Fluid Biomarkers: Revolutionizing MS Diagnosis
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
James R. Bateman, MD, MPH
Jerome A. Barakos, MD
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
B. Joy Snider, MD, PhD
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
Charles P. Vega, MD
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Michael Erdman, PharmD, BCCCP
Ali A. Habib, MD
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Perry Shieh, MD, PhD
The Multiple Faces of ATTRv-PN
Sami Khella, MD
Marcia Waddington-Cruz, MD, PhD
Shh…Gene-Silencing Therapies for ATTRv-PN
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
Diagnosing ATTRv-PN: What's in Your Toolbox?
Heads Up: It Might Be ATTRv Polyneuropathy – A Microlearning Course on Diagnosis and Treatment
John Berk, MD
Noel Dasgupta, MD, FACC
5 Things You Need to Know About Epilepsy & Depression
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.